dangar....I think I know where you are coming from so I decided to get my calculater out again......sorry philbar
Lets make some assumptions:
For ease of caculations at the time of listing:
Assume PRR ASX = $0.30 (30 cents)
Shares ASX = 1 Bil (approx)
Market cap = 1 Bil x 30 cents = $303 Mil
PMBD = $9.00 (= 30 underlying asx shares)
So...if demand on NADAQ causes an increase of 11% on the NASDAQ to $10.00, then the ASX should reflect a price of approx $0.33 (or 33 cents)
The company market cap should now reflect 1 Bil x 33 cents,
which is $333 Mil.
There are still 1 Bil shares "in the market" which is now spilt up between NASDAQ and ASX.
Based on the above assumptions for ASX PRR to reach $1.00 one of 2 things will need to happen.
NASDAQ demand will need to increase by 234% to $30.00 from $9.00, or ASX demand will need to increase by 234% to $1.00 from 30 cents.
Personally, I think it is easier for ASX demand to increase from 30 cents to $1 than it is for NASDAQ demand to go from $9 to $30.
But then again the Americans can see that there is money to be made in Bio.
Good luck to all.
- Forums
- ASX - By Stock
- IMM
- nasdaq sp
IMM
immutep limited
Add to My Watchlist
0.00%
!
24.0¢

nasdaq sp, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M |
Open | High | Low | Value | Volume |
24.0¢ | 25.5¢ | 24.0¢ | $740K | 3.015M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 597321 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 123304 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 573295 | 0.240 |
4 | 336102 | 0.235 |
9 | 304672 | 0.230 |
11 | 387839 | 0.225 |
20 | 1168265 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 123304 | 5 |
0.255 | 307829 | 7 |
0.260 | 341203 | 8 |
0.265 | 486184 | 4 |
0.270 | 53000 | 3 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online